Napredna pretraga

Pregled bibliografske jedinice broj: 598915

MMP-9 and TIMP-1 concentrations in plasma of patients with chronic obstructive pulmonary disease


Somborac Bačura, Anita; Rumora, Lada; Šribar, Dora; Popović-Grle, Sanja; Čepelak, Ivana; Žanić Grubišić, Tihana
MMP-9 and TIMP-1 concentrations in plasma of patients with chronic obstructive pulmonary disease // Biochemia Medica / Ana-Maria Šimundić (ur.).
Zagreb: Croatian Society for Medical Biochemistry and Laboratory Medicine, 2012. str. A147-A147 (poster, međunarodna recenzija, sažetak, znanstveni)


Naslov
MMP-9 and TIMP-1 concentrations in plasma of patients with chronic obstructive pulmonary disease

Autori
Somborac Bačura, Anita ; Rumora, Lada ; Šribar, Dora ; Popović-Grle, Sanja ; Čepelak, Ivana ; Žanić Grubišić, Tihana

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Biochemia Medica / Ana-Maria Šimundić - Zagreb : Croatian Society for Medical Biochemistry and Laboratory Medicine, 2012, A147-A147

Skup
2nd EFCC-UEMS European Joint Congress / 7th Congress of the Croatian Society of Medical Biochemistry and Laboratory Medicine: ''Laboratory Medicine at the Clinical Interface''

Mjesto i datum
Dubrovnik, Hrvatska, 10-13.10.2012

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
MMP-9 ; TIMP-1 ; chronic obstructive pulmonary disease

Sažetak
Background: An imbalance of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) has been implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). The aim of this study was to evaluate MMP-9 and TIMP-1 concentrations in COPD patients in relation to the severity of disease. Materials and methods: The study included patients with stable COPD (N=59) and healthy volunteers (N=21). COPD patients were divided into subgroups (GOLD stages II to IV) according to the spirometry results. Plasma MMP-9 and TIMP-1 concentrations were determined using a commercially available ELISA kits. Classic inflammatory markers were also measured (differential leukocyte counts and CRP). Results: MMP-9 concentration in COPD patients (204.13 (115.70-351.24) ng/mL) was significantly increased comparing to healthy controls (70.25 (52.48-104.96) ng/mL) with P<0.001. There were no significant differences in TIMP-1 concentration. MMP-9/TIMP-1 ratio differed significantly between COPD patients (1.659 (0.965-2.687)) and healthy controls (0.627 (0.424-0.890)) with P<0.001. Similar pattern was found already in GOLD II stage of disease. Very good diagnostic accuracy for MMP-9 was determined (AUC=0.884 ; sensitivity of 66.1% and specificity of 100.0% ; P<0.0001). The multivariate logistic regression model showed that the use of MMP-9 in combination with neutrophils, lymphocytes and CRP improved significantly (P=0.0232) diagnostic strength (AUC=0.975). Conclusions: Increased concentration of MPP-9 and higher MMP-9/TIMP-1 ratio found in COPD patients as early as in GOLD II stage highlight the significance of protease/antiprotease imbalance for the development of COPD and potential use of these parameters as biomarkers for early diagnosis of COPD.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Farmacija



POVEZANOST RADA


Projekt / tema
006-0061245-0977 - Molekularni mehanizmi patogeneze kronične opstrukcijske bolesti pluća (Tihana Žanić-Grubišić, )

Ustanove
Farmaceutsko-biokemijski fakultet, Zagreb

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE